STAT3 activates the lipoprotein lipase (LPL) gene that shifts the metabolic program of CLL cells towards an abnormal fatty acid oxidation and then to an abundant ROS production into the mitochondria [70]. This evidence concerns the gene STAT3 and B-cell chronic lymphocytic leukemia.